3B-302

N/A

Report date: 2025/01/26 15:56:25

Base Information

Drug Name3B-302
Drug Alias NameSPECT/PET imaging agent (3B Pharmaceuticals)clear cell renal cell carcinoma SPECT/PET imaging agent (3B Pharmaceuticals)3B-302
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCarbonic anhydrase IX modulators
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbH
China Registration ClassN/A

Develop Information

Active Companies3B Pharmaceuticals GmbH
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A